MIG Capital LLC purchased a new position in Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 968,057 shares of the company’s stock, valued at approximately $30,358,000. Celsius accounts for 3.7% of MIG Capital LLC’s holdings, making the stock its 12th largest position. MIG Capital LLC owned approximately 0.41% of Celsius as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of CELH. MetLife Investment Management LLC raised its stake in shares of Celsius by 2.2% in the 3rd quarter. MetLife Investment Management LLC now owns 89,074 shares of the company’s stock valued at $2,793,000 after buying an additional 1,877 shares in the last quarter. Cynosure Group LLC increased its holdings in Celsius by 78.8% during the 3rd quarter. Cynosure Group LLC now owns 22,034 shares of the company’s stock valued at $691,000 after purchasing an additional 9,710 shares in the last quarter. Townsquare Capital LLC bought a new position in shares of Celsius in the third quarter valued at about $494,000. BNP Paribas Financial Markets raised its stake in shares of Celsius by 35.0% in the third quarter. BNP Paribas Financial Markets now owns 181,821 shares of the company’s stock worth $5,702,000 after acquiring an additional 47,138 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in Celsius by 5.5% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 129,427 shares of the company’s stock worth $4,059,000 after purchasing an additional 6,731 shares during the last quarter. Institutional investors own 60.95% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on CELH shares. Jefferies Financial Group cut their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research report on Thursday, October 10th. B. Riley reduced their target price on Celsius from $50.00 to $47.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Maxim Group reduced their price target on shares of Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, September 5th. Truist Financial upped their price objective on Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, October 16th. Finally, Piper Sandler reduced their target price on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $54.40.
Insiders Place Their Bets
In other news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This trade represents a 3.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.20% of the company’s stock.
Celsius Price Performance
CELH stock opened at $28.37 on Thursday. Celsius Holdings, Inc. has a one year low of $25.23 and a one year high of $99.62. The stock has a market cap of $6.67 billion, a price-to-earnings ratio of 39.40, a price-to-earnings-growth ratio of 3.42 and a beta of 1.86. The company has a fifty day moving average price of $30.55 and a two-hundred day moving average price of $46.71.
Celsius Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- Which Wall Street Analysts are the Most Accurate?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is MarketRankā¢? How to Use it
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- When to Sell a Stock for Profit or Loss
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.